Danderyd, 2012-04-26 14:14 CEST (GLOBE NEWSWIRE) -- Stockholm, 28 April 2012
XCounter AB (publ)
Result from AGM
XCounter AB (publ) (Nasdaq OMX First North: XCT), a technology leader in direct conversion and photon counting digital X-ray imaging for medical, dental and industrial markets, held its Annual General Meeting earlier today, Thursday 26 April, at which all resolutions were duly passed.
At the AGM the members of the Board of Directors and alternate Directors were re-elected and the no fees decision remains unchanged.
It was furthermore decided to issue 99 713 new shares to the former CEO, Mikael Strindlund, and to decide a grant of 10 000 warrants to the current CEO, Fredrik Henckel. The full details for those decisions can be found at XCounter’s website at Investor information.
For further information, please contact:
| XCounter AB | |
| Fredrik Henckel – CEO | +46 (0) 8 622 23 17 |
|
Jean-Philippe Flament – Chairman |
+33 680 869 787 |
| Mangold Fondkommission (Certified advisor) | +46 (8) 5030 1550 |
| Erik Josefsson | |
About XCounter AB
XCounter AB is a leader in the development and supply of direct conversion, photon counting and tomosynthesis based 3D X-ray imaging technologies for medical, dental and industrial X-ray imaging. The Company recently delisted from AIM London and relisted to Nasdaq OMX First North.
Headquartered in Stockholm, XCounter employs 35 people in its facilities in Sweden and Finland. For more detailed information, please visit: www.xcounter.se
